iPSCs derived from lymphoblasts from two LOAD patients carrying the TREM2 R47H risk variant (AD2-2 and AD2-4), as well as aged-matched control individuals without dementia (CON8 and CON9) were used for this study [40,41,42,43]. This evidence concerns the gene TREM2 and dementia.